Safety and efficacy of blinatumomab as bridge-to-transplant for B-cell acute lymphoblastic leukemia in first complete remission with no detectable minimal residual disease.
作者信息
Lu Jialing, Bao Xiebing, Zhou Jihao, Li Xiaoli, He Zhewei, Ji Yujie, Xue Shengli, Chen Suning, Wu Depei, Hu Qi, Ke Peng, Ma Xiao
机构信息
Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China.
出版信息
Blood Cancer J. 2024 Aug 23;14(1):143. doi: 10.1038/s41408-024-01127-2.
Abstract
摘要
Zotero 插件